Stock listing
NASDAQ:IMMU Immunomedics Inc Stock
Follow Immunomedics Inc into a list and get an email when it puts out news.
Last close · NASDAQ:IMMU
$87.86 USD
Close on Oct 22, 2020 · No longer trades
- Lowest – highest close
- $0.84 – $87.86 USDSince Jun 24, 1985 · lowest Mar 5, 2009 · highest Oct 22, 2020
Delisted NASDAQ:IMMU no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.
- Ticker
- NASDAQ:IMMU
- Asset type
- Stock
- Exchange
- NASDAQ
- Currency
- USD
Immunomedics Inc on 6ix
- Decks
- 8 decks · latest Aug 5, 2020
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Q2 2020 Earnings Presentation | Earnings | 23 slides | Aug 5, 2020 |
| Proxy Contest (February 2017) | Proxy contest | 23 slides | Feb 10, 2017 |
| Proxy Contest (January 2017) | Proxy contest | 19 slides | Jan 30, 2017 |
| Proxy Contest (January 2017) | Proxy contest | 29 slides | Jan 27, 2017 |
| Proxy Contest (January 2017) | Proxy contest | 38 slides | Jan 26, 2017 |
| Investor Day (January 2017) | Investor day | 122 slides | Jan 18, 2017 |
| Proxy Contest (January 2017) | Proxy contest | 28 slides | Jan 18, 2017 |
| Proxy Contest (December 2016) | Proxy contest | 24 slides | Dec 14, 2016 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Robert Azelby Other companies: Tango Therapeutics, Inc. (Chairman; Former President and CEO, Eliem Therapeutics, Inc. · Since at least Jun 19, 2026); Autolus Therapeutics plc (Director · Since at least Mar 18, 2026); Terns Pharmaceuticals, Inc. (Director · Since at least Feb 20, 2025); Cardinal Health, Inc. (Director · Since at least Mar 1, 2024); ADC Therapeutics SA (Director · Since at least Jan 2, 2024); Aduro Biotech Inc (Director · Apr 10, 2023 – Aug 11, 2023 · Past); Climb Bio, Inc. (President & CEO, Director · Aug 9, 2021 – Oct 31, 2022 · Past); Clovis Oncology Inc (Director · Oct 11, 2018 – Jun 10, 2021 · Past); Alder BioPharmaceuticals Inc (President and CEO, Director · Jun 13, 2018 – Oct 22, 2019 · Past); Cascadian Therapeutics Inc (Director · Mar 31, 2017 – Mar 9, 2018 · Past); Juno Therapeutics Inc (EVP & Chief Commercial Officer · Nov 1, 2015 – Mar 5, 2018 · Past) | Director · Feb 26, 2020 – Oct 23, 2020 · Past |
| Peter P Pfreundschuh Other companies: Y mAbs Therapeutics (EVP, CFO and Treasurer · Since at least Jun 28, 2024); Voyager Therapeutics, Inc. (Chief Financial Officer · Sep 19, 2022 – Feb 21, 2024 · Past); Korro Bio, Inc. (Chief Financial Officer · Dec 1, 2020 – Feb 18, 2022 · Past); UroGen Pharma Ltd. (Chief Financial Officer · Jan 1, 2019 – Oct 15, 2020 · Past); Sucampo Pharmaceuticals Inc (CFO · Mar 20, 2017 – Feb 13, 2018 · Past) | Chief Financial Officer · Aug 20, 2015 – Aug 20, 2015 · Past |
| Scott A Canute Other companies: Oncorus Inc (Director · Dec 11, 2020 – Jun 23, 2022 · Past); Flexion Therapeutics Inc (Director · Jun 20, 2018 – Nov 19, 2021 · Past); Akebia Therapeutics, Inc. (Director · Jun 14, 2018 – Jun 6, 2019 · Past); Protara Therapeutics, Inc. (Director · Jun 8, 2018 – Jun 8, 2018 · Past); Outlook Therapeutics, Inc. (Director · Oct 26, 2017 – Oct 26, 2017 · Past) | Director · Apr 2, 2018 – Oct 23, 2020 · Past |
| Behzad Aghazadeh Other companies: Scribe Therapeutics Inc. (Director · Since at least Jul 23, 2026); Whitehawk Therapeutics, Inc. (Director · Since at least Aug 26, 2021) | Director · Oct 23, 2020 – Oct 23, 2020 · Past |
| Bryan Ball Other companies: Whitehawk Therapeutics, Inc. (Chief Technical Operations Officer · Since at least Apr 23, 2024); Intercept Pharmaceuticals Inc (Chief Qual. Officer & SVP Ops. · Jan 11, 2021 – Jul 11, 2022 · Past) | Chief Quality Officer · Mar 5, 2019 – Oct 23, 2020 · Past |
| Lorettta M Itri Other companies: Whitehawk Therapeutics, Inc. (CHIEF MEDICAL OFFICER · Oct 21, 2021 – Mar 1, 2024 · Past) | Chief Medical Officer · Oct 23, 2020 – Oct 23, 2020 · Past |
| Morris Rosenberg Other companies: Seagen Inc (EVP, Process Sciences · Mar 13, 2012 – Jun 12, 2012 · Past) | Chief Technology Officer · Apr 12, 2018 – Sep 6, 2019 · Past |
| William Fricker Other companies: NRX Pharmaceuticals, Inc. (CFO & Treasurer · May 24, 2021 – May 24, 2021 · Past) | Principal Accounting Officer · Aug 23, 2018 – Oct 23, 2020 · Past |
Log in to ask 6ix AI your own questions about Immunomedics Inc.